Drug Profile
Research programme: estrogen receptor agonists - Organon
Alternative Names: ORG 239235; ORG 41749; ORG 50426Latest Information Update: 16 Nov 2009
Price :
$50
*
At a glance
- Originator Organon
- Class
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Female genital diseases; Menopausal syndrome
Most Recent Events
- 07 Dec 2007 Preclinical development is ongoing
- 19 Nov 2007 Organon has been acquired by Schering-Plough
- 31 Dec 2006 Preclinical trials in Menopausal syndrome in USA (unspecified route)